Diabetic Nephropathy
|
0.100 |
Biomarker
|
disease |
BEFREE |
Diabetic nephropathy (DN) is the leading cause of end-stage renal disease.
|
16813599 |
2006 |
Diabetic Nephropathy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Genotyping the -463G/A polymorphism in HN, chronic glomerulonephritis (CGN) and diabetic nephropathy (DM) patients who were under hemodialysis treatment demonstrated that the GG genotype was more frequent in the HN group than in the CGN and DM groups.
|
18344624 |
2007 |
Diabetic Nephropathy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Considering the role of aldosterone in diabetic nephropathy, genetic polymorphism of this gene may contribute to the development and progression of diabetic nephropathy.
|
18771471 |
2008 |
Diabetic Nephropathy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Genetic variation at the AGT gene influences the risk of nephropathy in T2DM patients but not extent of DN severity, and thus represents a potential DN genetic susceptibility locus worthy of replication.
|
21421655 |
2011 |
Diabetic Nephropathy
|
0.100 |
Biomarker
|
disease |
BEFREE |
Diabetic nephropathy (DN) was categorized by urinary albumin excretion (UAE) as normoalbuminuria (n=247), microalbuminuria (n=68), macroalbuminuria (n=70), or the presence of end-stage renal disease (dialysis; n=134).
|
20097100 |
2011 |
Diabetic Nephropathy
|
0.100 |
Biomarker
|
disease |
BEFREE |
Diabetic nephropathy (DN) is a major cause of end stage kidney disease and a strong risk factor for cardiovascular diseases.
|
24361893 |
2014 |
Diabetic Nephropathy
|
0.100 |
Biomarker
|
disease |
BEFREE |
Diabetic nephropathy (DN) is the most common cause of end-stage renal disease and identification of new therapeutic targets is needed.
|
24287278 |
2014 |
Diabetic Nephropathy
|
0.100 |
Biomarker
|
disease |
BEFREE |
Diabetic nephropathy (DN) is a major microvascular complication that develops in nearly 20-30% of patients with type 2 diabetes (T2D) and is currently the leading cause of end stage renal disease (ESRD).
|
25154422 |
2015 |
Diabetic Nephropathy
|
0.100 |
Biomarker
|
disease |
BEFREE |
This study aimed to obtain a comprehensive understanding of the TCM method "kidney-tonifying" in the treatment of DN by conducting a meta-analysis to analyze the clinical efficacy of decoctions made from the LDWCFs in the treatment of DN proteinuria.
|
30356440 |
2018 |
Diabetic Nephropathy
|
0.100 |
Biomarker
|
disease |
BEFREE |
Diabetic nephropathy (DN) has become the major complication of diabetes.
|
30575943 |
2018 |
Diabetic Nephropathy
|
0.100 |
Biomarker
|
disease |
BEFREE |
Diabetic nephropathy (DN) is the second most frequent and prevalent complication of diabetes mellitus (DM).
|
29808088 |
2018 |
Diabetic Nephropathy
|
0.100 |
Biomarker
|
disease |
BEFREE |
Five highly significant and consistently dysregulated miRNAs were identified, and future studies should focus on discovering their potential effect on DN and their clinical value as DN biomarkers and therapeutic mediators.
|
30019103 |
2018 |
Diabetic Nephropathy
|
0.100 |
Biomarker
|
disease |
BEFREE |
Diabetic nephropathy (DN) occurrence in transplanted kidneys is poorly investigated.
|
30526503 |
2018 |
Diabetic Nephropathy
|
0.100 |
Biomarker
|
disease |
BEFREE |
Diabetic nephropathy (DN) is a major complication in diabetic patients.
|
30486327 |
2018 |
Diabetic Nephropathy
|
0.100 |
Biomarker
|
disease |
BEFREE |
Diabetic nephropathy (DN) is one of the most devastating complications of diabetes mellitus.
|
30420491 |
2018 |
Diabetic Nephropathy
|
0.100 |
Biomarker
|
disease |
BEFREE |
Diabetic nephropathy (DN) is a major complication of diabetes.
|
30867431 |
2019 |
Diabetic Nephropathy
|
0.100 |
Biomarker
|
disease |
BEFREE |
Diabetic nephropathy (DN) is a major complication of diabetes.
|
31601446 |
2019 |
Diabetic Nephropathy
|
0.100 |
Biomarker
|
disease |
BEFREE |
Diabetic nephropathy (DN) is one of the most serious chronic complications of diabetes mellitus (DM).
|
31359358 |
2019 |
Diabetic Nephropathy
|
0.100 |
Biomarker
|
disease |
BEFREE |
<b>Background:</b> Diabetic nephropathy (DN) is the leading cause of end-stage failure of the kidneys; however, its pathogenesis remains unknown.
|
31338070 |
2019 |
Diabetic Nephropathy
|
0.100 |
Biomarker
|
disease |
BEFREE |
Diabetic nephropathy (DN) was induced in male C57BL/6 mice by the injection of streptozotocin (STZ, 50 mg kg<sup>-1</sup>) in citrate buffer on 5 consecutive days.
|
31363726 |
2019 |
Diabetic Nephropathy
|
0.100 |
Biomarker
|
disease |
BEFREE |
Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation and Study of Diabetic Nephropathy with Atrasentan: what was learned about the treatment of diabetic kidney disease with canagliflozin and atrasentan?
|
31198532 |
2019 |
Diabetic Nephropathy
|
0.100 |
Biomarker
|
disease |
BEFREE |
Diabetic nephropathy (DN) affects about 40% of diabetes mellitus (DM) patients and is the leading cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) all over the world, especially in high- and middle-income countries.
|
31409386 |
2019 |
Diabetic Nephropathy
|
0.100 |
Biomarker
|
disease |
BEFREE |
Diabetic nephropathy (DN) is serious diabetic complication with capillary injury.
|
30834596 |
2019 |
Diabetic Nephropathy
|
0.100 |
Biomarker
|
disease |
BEFREE |
Therefore, this paper conducted a meta-analysis of the clinical efficacy of acupuncture in the treatment of DN proteinuria, in order to comprehensively analyze the role of acupuncture in the treatment of DN.
|
31764774 |
2019 |
Diabetic Nephropathy
|
0.100 |
Biomarker
|
disease |
BEFREE |
Diabetic Nephropathy (DN) is the most common cause of end-stage renal disease associated with high mortality worldwide.
|
31188032 |
2019 |